SCHEMBL52346

SCHEMBL52346

CN(C(=O)O)C(C#N)(Cc1ccccc1)C1CCC(CO[Si](C)(C)C(C)(C)C)C1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
CHRM2 P08172 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM3 P20309 2/20 0.32
DPP4 P27487 1/20 0.32
CTSS P25774 2/20 0.31
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31
CNR2 P34972 1/20 0.30
NPY5R Q15761 1/20 0.30
TOP2A P11388 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
NPBWR1 P48145 1/20 0.30
KMT2A Q03164 1/20 0.30
MCHR1 Q99705 1/20 0.30
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117733 0.77 MEN1 (0.33) DPP4CTSSCTSLCTSBCNR2
SCHEMBL1117736 0.77 DPP4 (0.31) DPP4
SCHEMBL63495 0.70 ITGB3 (0.37) CTSSCTSLCTSBCYP3A4CTSK
SCHEMBL2633971 0.67
SCHEMBL25699119 0.66 TOP2A (0.40) JAK2JAK1TOP2AALDH1A1KMT2A
SCHEMBL63843 0.66 PTGIR (0.38) CHRM2CHRM1CHRM3CTSSCTSL
SCHEMBL6392396 0.65 CXCR4 (0.47) JAK2JAK1CYP3A4CYP2C9CYP2C19
SCHEMBL6243074 0.65 LMNA (0.33) CNR2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL6695021 0.65 LMNA (0.33) CNR2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL1117710 0.65 CTSK (0.32) TOP2ACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280981-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-02-09 EP disclosed